Nathalie Dussault

TL;DR: In this paper, the authors select plasma from a cohort of convalescent patients with COVID-19 and selectively deplete immunoglobulin A, M or G before testing the remaining neutralizing capacity of the depleted plasma.

TL;DR: The residual cell content of these LRS chambers was characterized to determine whether it would be a valuable source of viable human blood cells.

TL;DR: It is found that depletion of immunoglobulin M was associated with the most substantial loss of virus neutralization, followed by immunoglOBulin G, which may help design efficient antibody-based COVID-19 therapies and may also explain the increased susceptibility to SARS-CoV-2 of autoimmune patients receiving therapies that impair the production of IgM.

TL;DR: Whether these filter‐derived cells could also be used to prepare frozen cell banks to facilitate work organization and open new avenues for their utilization as references in physiological studies and clinical investigations was investigated.

TL;DR: The finding that SRC expression is inducible and correlates with stimulation by CD154 and the proliferation of the B cells suggests that Src may play a specific role in normal and transformed B cell activation/proliferation pathways mediated primarily through CD40 stimulation.